Mohammed Al Musawa

Ceftolozane-Tazobactam Versus Ceftazidime-Avibactam for the Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa: a Multicenter Cohort Study

Thamer A. Almangour, Leen Ghonem, Dareen Alassiri et al. · Antimicrobial Agents and Chemotherapy · 2023 · 42 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Ceftazidime-Avibactam versus Colistin for the Treatment of Infections Due to Carbapenem-Resistant Enterobacterales: A Multicenter Cohort Study

Thamer A. Almangour, Leen Ghonem, Ahmad Aljabri et al. · Dove Medical Press (Taylor and Francis Group) · 2022 · 38 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Ceftolozane-tazobactam vs. colistin for the treatment of infections due to multidrug-resistant Pseudomonas aeruginosa: a multicentre cohort study

Thamer A. Almangour, Ahmad Aljabri, Mohammed Al Musawa et al. · Journal of Global Antimicrobial Resistance · 2022 · 33 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia Infections

Mohammed Al Musawa, Ashlan J. Kunz Coyne, Sara Alosaimy et al. · Infectious Diseases and Therapy · 2025 · 10 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14